🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is an open-label Phase 1 single dose-escalation safety study of C...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2018-10-15
Trial ID
NCT03464916
Treatments Being Tested
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
This laboratory study is looking into biomarkers in samples from younger pa...
Status
Completed
Location
Children's Oncology Group
Start Date
2012-08
Trial ID
NCT01642121
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
The study will begin with a two-week lead-in period (W-2 and W-1), when par...
Status
Recruiting
Location
RDSS Research Center
Start Date
2023-07-20
Trial ID
NCT06676410
Treatments Being Tested
This 2-arm, multi-center, open-label, parallel-group phase II trial will as...
Status
Completed
Location
Managadze National Center of Urology
Start Date
2021-01-20
Trial ID
NCT04733040
Treatments Being Tested
The purpose of this study is to identify preventive treatments that can min...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-08-26
Trial ID
NCT06500884
Treatments Being Tested
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-11-30
Trial ID
NCT04407442
Treatments Being Tested
This Phase II, open-label, multicenter study will evaluate teclistamab in c...
Status
Not Yet Recruiting
Location
AUH
Start Date
2026-09-01
Trial ID
NCT07757412
Treatments Being Tested
Multiple myeloma (MM) is an incurable malignancy and accounts for 1 percent...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-18
Trial ID
NCT03525678
Treatments Being Tested